Literature DB >> 11740218

Screening for mutations of Axenfeld-Rieger syndrome caused by FOXC1 gene in Japanese patients.

C Kawase1, K Kawase, T Taniguchi, K Sugiyama, T Yamamoto, Y Kitazawa, W L Alward, E M Stone, D Y Nishimura, V C Sheffield.   

Abstract

PURPOSE: Mutations in the forkhead transcription factor gene (FOXC1) have been recently shown to cause some cases of juvenile glaucoma associated with a variety of anterior-segment anomalies. The purpose of this study was to investigate the clinical features of Axenfeld-Rieger syndrome caused by FOXC1 mutations in Japanese patients. PATIENTS AND METHODS: After informed consent was obtained, genomic DNA was isolated from peripheral blood. The DNA-sequence changes were analyzed using single-strand conformation polymorphism analysis and automated sequencing in six Japanese probands with Axenfeld-Rieger syndrome.
RESULTS: The authors identified four mutations: pedigree 1 (26-47ins22), 2 (Ile91Ser), 3 (286ins1), and 4 (Arg127His). Two pedigrees showed new mutations in FOXC1. In pedigrees 1,2, and 4, younger generations had iris hypoplasia with severe early-onset glaucoma, whereas their parents had posterior embryotoxon without glaucoma. Pedigree 3 had a single affected person with iris hypoplasia and posterior embryotoxon with a mild increase of intraocular pressure.
CONCLUSION: Four different FOXC1 mutations were found in four of six Japanese pedigrees with Axenfeld-Rieger syndrome. This was a new mutation in two pedigrees that was not found in earlier generations. This study confirms that mutations in this gene cause maldevelopment of the anterior segment of the eye.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11740218     DOI: 10.1097/00061198-200112000-00007

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  9 in total

1.  Essential structural and functional determinants within the forkhead domain of FOXC1.

Authors:  R A Saleem; S Banerjee-Basu; T C Murphy; A Baxevanis; M A Walter
Journal:  Nucleic Acids Res       Date:  2004-08-06       Impact factor: 16.971

2.  [Morphology, family history, and age at diagnosis of 26 patients with Axenfeld-Rieger syndrome and glaucoma or ocular hypertension].

Authors:  P Dressler; E Gramer
Journal:  Ophthalmologe       Date:  2006-05       Impact factor: 1.059

3.  A novel mutation of FOXC1 in a Chinese family with Axenfeld-Rieger syndrome.

Authors:  Xing Wu; Hai-Nan Xie; Tong Wu; Wei Liu; Lan-Lam Chen; Zhao-Hui Li; Da-Jiang Wang; Yi Wang; Hou-Bin Huang
Journal:  Exp Ther Med       Date:  2019-07-18       Impact factor: 2.447

4.  Clinical course during 40-year follow-up of Axenfeld-Rieger syndrome in a Japanese family.

Authors:  Shigeo Yoshida; Aki Miyazaki; Keijiro Ishikawa; Yasuhiro Ikeda; Kimihiko Fujisawa; Tatsuro Ishibashi
Journal:  Oman J Ophthalmol       Date:  2010-01

5.  Novel mutations in the FOXC1 gene in Japanese patients with Axenfeld-Rieger syndrome.

Authors:  Nobuo Fuse; Kana Takahashi; Shunji Yokokura; Kohji Nishida
Journal:  Mol Vis       Date:  2007-06-27       Impact factor: 2.367

Review 6.  Childhood glaucoma genes and phenotypes: Focus on FOXC1 mutations causing anterior segment dysgenesis and hearing loss.

Authors:  Angela C Gauthier; Janey L Wiggs
Journal:  Exp Eye Res       Date:  2019-12-11       Impact factor: 3.467

7.  A Novel Mutation in FOXC1 in a Lebanese Family with Congenital Heart Disease and Anterior Segment Dysgenesis: Potential Roles for NFATC1 and DPT in the Phenotypic Variations.

Authors:  Athar Khalil; Christiane Al-Haddad; Hadla Hariri; Kamel Shibbani; Fadi Bitar; Mazen Kurban; Georges Nemer; Mariam Arabi
Journal:  Front Cardiovasc Med       Date:  2017-09-20

Review 8.  Research progress on the forkhead box C1.

Authors:  Jinhua Wang; Wan Li; Xiangjin Zheng; Xiaocong Pang; Guanhua Du
Journal:  Oncotarget       Date:  2017-11-20

9.  Gene-specific facial dysmorphism in Axenfeld-Rieger syndrome caused by FOXC1 and PITX2 variants.

Authors:  Emmanuelle Souzeau; Owen M Siggs; Francesca Pasutto; Lachlan S W Knight; Luis A Perez-Jurado; Lesley McGregor; Shannon Le Blanc; Christopher P Barnett; Jan Liebelt; Jamie E Craig
Journal:  Am J Med Genet A       Date:  2020-11-24       Impact factor: 2.578

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.